Samsrita Labs Ltd.
Snapshot View

30.45 -3.90 ▼-11.4%

07 December 2022, 03:45:00 PM
Volume: 29,070

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.drhlsl.com
Market Cap 45.09 Cr.
Enterprise Value(EV) 47.98 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 1.02 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 29.72 Trailing Twelve Months Ending 2022-09
Industry PE 50.11 Trailing Twelve Months Ending 2022-09
Book Value / Share 8.95 Trailing Twelve Months Ending 2022-09
Price to Book Value 3.40 Calculated using Price: 30.45
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.48 Cr. 14,808,706 Shares
FaceValue 10
Company Profile
Dr Habeebullah Life Sciences with its group Companies has established platforms in the areas of Stem Cell Research and Therapy, New Drug Discovery, Molecular Prognosis and Diagnostics services, CRO, Stem Cell focused Super Specialty Hospital, RNA Interference Technology and Medical Devices.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-11.35%
1 Week
+7.41%
1 Month
+1.67%
3 Month
+18.95%
6 Month
+22.29%
1 Year
+19.18%
2 Year
-36.76%
5 Year
-9.51%
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 1.78 0.72 0.38 -5.26 -10.93 -18.92 -15.29 -6.35 11.94
Return on Capital Employed (%) 1.81 0.73 0.38 -5.25 -10.08 -16.44 -13.30 -5.41 9.95
Return on Assets (%) 1.58 0.52 0.24 -4.56 -9.86 -15.60 -11.76 -4.51 8.71

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 4 4 4 8 12 13 12 12 13 13
Non Curr. Liab. 0 0 0 0 0 0
Curr. Liab. 0 3 2 0 0 2 4 5 4 4
Minority Int.
Equity & Liab. 4 6 6 8 12 15 17 17 17 17
Non Curr. Assets 1 0 0 5 8 9 10 10 10 10
Curr. Assets 3 6 5 3 4 6 7 7 7 7
Misc. Exp. not W/O
Total Assets 4 6 6 8 12 15 17 17 17 17

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 4 4 1 1 2 1 0 0 0
Other Income 0 0 0 0 0 0 0 2 2
Total Income 0 4 4 1 1 2 2 0 2 2
Total Expenditure 0 -4 -4 -2 -2 -4 -3 -1 0 0
PBIDT 0 0 0 0 -1 -2 -2 -1 2 2
Interest 0 0
Depreciation 0 0 0 0
Taxation
Exceptional Items
PAT 0 0 0 0 -1 -2 -2 -1 2 2
Adjusted EPS 0 0 0 0 -1 -2 -1 -1 1 1

Cash Flow View Details >>

Particulars 9 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -1 0 0 -3 -3 -1 0 0
Cash Fr. Inv. -1 1 -5 -1 -1 -1 0
Cash Fr. Finan. 1 5 5 4 2 1 0
Net Change 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 58.27 58.27 58.27 58.27 58.27 58.27 52.87 52.87 52.87
Public 41.73 41.73 41.73 41.73 41.73 41.73 47.13 47.13 47.13
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 10 Nov 2022
Disclosure Of Related Party Transactions.
Disclosure of related party transactions.
Sat, 29 Oct 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Unaudited financial results for 30.09.2022
Fri, 28 Oct 2022
Board Meeting Outcome for For The Unaudited Financial Results For The Quarter Ended 30.09.2022
For the unaudited financial results for the quarter ended 30.09.2022

Technical Scans View Details >>

Wed, 07 Dec 2022
Making Higher Highs for 3 days Making Higher Highs for 3 days
High Increase 3 Months High Increase 3 Months
High Increase 6 Months High Increase 6 Months
RSI Bearish RSI Bearish
MFI Bearish MFI Bearish

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 244,600.20 1,017.75 -1.5%
Cipla Ltd. 89,185.65 1,105.30 -0.4%
Divi's Laboratories Ltd. 88,620.05 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. 72,619.02 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. 67,995.76 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. 55,031.23 1,629.00 +0.9%
Abbott India Ltd. 42,993.71 20,208.95 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 59.59 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-09 34.76 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-09 29.63 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.32 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 80.98 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 69.05 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-09 48.76 20,208.95 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.60 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-09 4.08 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-09 7.31 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.49 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.36 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.03 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-09 15.84 20,208.95 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-03 0.00 20,208.95 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-03 29.95 20,208.95 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-03 29.95 20,208.95 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,208.95 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-03 798.70 20,208.95 +0.1%

FAQ's On Samsrita Labs Ltd.

What is Samsrita Labs share price?

Can I buy Samsrita Labs shares now?

What is the Market Cap of Samsrita Labs?

What are the key metrics to analyse Samsrita Labs?

What is the 52 Week High and Low of Samsrita Labs?

What is the trend of Samsrita Labs share price?